COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 147 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q1 2019. The put-call ratio across all filers is 0.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $1,409,000 | +5.9% | 93,041 | +20.1% | 0.00% | 0.0% |
Q4 2018 | $1,330,000 | -41.5% | 77,464 | -49.7% | 0.00% | +100.0% |
Q3 2018 | $2,272,000 | +31.3% | 154,072 | +112.4% | 0.00% | -50.0% |
Q2 2018 | $1,730,000 | +0.9% | 72,552 | +8.1% | 0.00% | 0.0% |
Q1 2018 | $1,714,000 | +39.6% | 67,088 | +0.8% | 0.00% | 0.0% |
Q4 2017 | $1,228,000 | +95.9% | 66,533 | +11.3% | 0.00% | +100.0% |
Q3 2017 | $627,000 | -15.8% | 59,794 | +0.3% | 0.00% | 0.0% |
Q2 2017 | $745,000 | +146.7% | 59,590 | +98.8% | 0.00% | – |
Q1 2017 | $302,000 | -23.7% | 29,973 | +17.8% | 0.00% | -100.0% |
Q4 2016 | $396,000 | -4.6% | 25,437 | +18.1% | 0.00% | 0.0% |
Q3 2016 | $415,000 | +62.7% | 21,545 | 0.0% | 0.00% | – |
Q2 2016 | $255,000 | +25.0% | 21,545 | +91.5% | 0.00% | – |
Q1 2016 | $204,000 | -23.0% | 11,249 | +16.6% | 0.00% | – |
Q4 2015 | $265,000 | +24.4% | 9,649 | 0.0% | 0.00% | – |
Q3 2015 | $213,000 | +23.8% | 9,649 | 0.0% | 0.00% | – |
Q2 2015 | $172,000 | – | 9,649 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Rubric Capital Management LP | 2,606,500 | $48,689,000 | 2.30% |
Camber Capital Management LP | 1,050,000 | $19,614,000 | 0.67% |
OneAscent Wealth Management LLC | 14,131 | $264,000 | 0.66% |
Eventide Asset Management | 2,629,593 | $49,121,000 | 0.63% |
CLARK ESTATES INC/NY | 183,800 | $3,433,000 | 0.50% |
Values First Advisors, Inc. | 42,312 | $790,000 | 0.47% |
RICE HALL JAMES & ASSOCIATES, LLC | 704,201 | $13,154,000 | 0.47% |
EMERALD MUTUAL FUND ADVISERS TRUST | 650,398 | $12,149,000 | 0.43% |
OneAscent Financial Services LLC | 11,774 | $220,000 | 0.42% |
Factorial Partners, LLC | 33,300 | $622,000 | 0.41% |